Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-03-20

FDA Approved: ZIAGEN — Supplemental Application (ViiV Healthcare Company)

View source ↗

Summary

The FDA approved a supplemental application for Ziagen (abacavir sulfate) filed by ViiV Healthcare Company. This action updates the labeling/indication as appro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ziagen (Abacavir)

Snippet

SUPPL AP for ZIAGEN (ABACAVIR SULFATE)